U-Blot® Research Grade MeplazumabCat. No. WA3148$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade MeplazumabCat. No. WA3148
U-Blot® Research Grade MelrilimabCat. No. WA3147
U-Blot® Research Grade Melredableukin AlfaCat. No. WA3146
U-Blot® Research Grade MEDI3185Cat. No. WA3145
U-Blot® Research Grade MecbotamabCat. No. WA3144
U-Blot® Research Grade mebarase alfaCat. No. WA3143
U-Blot® Research Grade MDX-1342Cat. No. WA3142
U-Blot® Research Grade MazorelvimabCat. No. WA3141
U-Blot® Research Grade mavrostobartCat. No. WA3140
U-Blot® Research Grade MavrilimumabCat. No. WA3139
U-Blot® Research Grade MatuzumabCat. No. WA3138
U-Blot® Research Grade MaslimomabCat. No. WA3137